While temporary inhibition of p53 or other cell death pathway components may spare sensitive normal tissues from radiation injury, it is also possible that by preventing the death of cells damaged by radiation late effects, including cancer development, may be exacerbated. This evidence concerns the gene TP53 and cancer.